Medications News

Resveratrol May Hinder, Not Aid, Some Physical Training

November 3rd, 2014
New research suggests that use of the supplement resveratrol (RSV) may not enhance the effects of high-intensity interval training (HIIT). The finding is contrary to popular belief as many news outlets and health blogs have recommended RSV as a complement to exercise and ...

One-Fifth of Schizophrenia Cases Could Involve Parasite

November 2nd, 2014
The hypotheses that schizophrenia may be linked to Toxoplasma gondii (T. gondii) -- a parasite transmitted by soil, undercooked meat, and cat feces -- is still viewed with skepticism. A new study, however, suggests that about one-fifth of cases may involve the ...

Ketamine Used to Counter Loss of Pleasure in Bipolar Depression

November 1st, 2014
Ketamine, recently the focus of research as a rapid-acting antidepressant that can ease symptoms within hours instead of weeks, is now being studied as a fast-acting mood-lifter to treat bipolar patients. In a National Institutes of Health (NIH) trial, the drug -- sometimes referred to ...

Sleep Apnea Affects REM Sleep and Memory

October 31st, 2014
New research suggests sleep apnea may disrupt the formation of new spatial memories. Spatial memories are used every day and act as our internal compass to keep us from getting lost, remember where we left the keys, or parked the car. Sleep ...

1 in 5 Americans Face Chronic Pain

October 28th, 2014
A new analysis suggests nearly one in five U.S. adults are in pain most every day for spells of three months or longer. Researchers estimate the 39 million adults in persistent pain outnumber the residents of our most populous state, California. According to previous ...

Study Probes Biochemical Basis for Seasonal Depression

October 27th, 2014
As the days get shorter, for many the risk of depression increases. New research from the European College of Neuropsychopharmacology conference in Berlin confirms why some people suffer from the winter blues while others get through the winter without any problems. The new study ...

Software Model Predicts Risk of Depression Relapse

October 23rd, 2014
German neuroscientists have written a software program that they believe can calculate the risk for experiencing a major depression relapse. For the project, Selver Demic, M.D., of the Ruhr University Bochum and his colleagues from the Mercator Research Group examined a variety of factors ...

Some OTC Meds May Help Reduce Depression Symptoms

October 22nd, 2014
A review of studies of more than 6,000 patients suggests ordinary over-the-counter painkillers and anti-inflammatory drugs may aid in the treatment of depression, when taken in combination with antidepressants. The meta-analysis, recently published in JAMA Psychiatry, is the work of researchers from Aarhus University ...

Some Anti-Inflammatory Drugs May Aid Schizophrenia Treatment

October 21st, 2014
Emerging research suggests that some anti-inflammatory medicines can improve the efficacy of existing schizophrenia treatments. A group of researchers at the University of Utrecht in the Netherlands discovered anti-inflammatory medicines such as aspirin, estrogen, and fluimucil can help improve schizophrenia symptoms. This work was ...

Changes Suggested for Drug-Naming Conventions

October 20th, 2014
European psychiatrists and other health experts are calling for a change in the way mental health drugs are named. The reason for the switch is that the name of the drug you are prescribed may significantly influence the way you respond to the ...